Jeannie T. Lee
Director/Miembro de la Junta en GSK PLC .
Perfil
Jeannie T.
Lee is the founder of Translate Bio, Inc. (founded in 2011) and Fulcrum Therapeutics, Inc. (founded in 2015).
She is currently the Director at The Genetics Society of America and a Non-Executive Director at GSK Plc (starting in 2024).
Dr. Lee has an undergraduate degree from Harvard University and a doctorate from Perelman School of Medicine.
Cargos activos de Jeannie T. Lee
| Empresas | Cargo | Inicio |
|---|---|---|
| GSK PLC | Director/Miembro de la Junta | 04/03/2024 |
| The Genetics Society of America | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Jeannie T. Lee.
| Empresas | Cargo | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Fundador | - |
| FULCRUM THERAPEUTICS, INC. | Fundador | - |
Formación de Jeannie T. Lee.
| Harvard University | Undergraduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GSK PLC | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
| The Genetics Society of America |
- Bolsa de valores
- Insiders
- Jeannie T. Lee
